Clinical Trial: Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Intravitreal Bevacizumab for the Treatment of Neovascular Membranes in Patients With Intraocular Inflammation
Brief Summary: Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.
Detailed Summary:
Sponsor: Asociación para Evitar la Ceguera en México
Current Primary Outcome:
- Best corrected visual acuity
- Retinal thickness by OCT
- Leakage in Fluorescein angiogram
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Asociación para Evitar la Ceguera en México
Dates:
Date Received: December 1, 2006
Date Started: August 2006
Date Completion: November 2006
Last Updated: December 1, 2006
Last Verified: December 2006
